| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.45B | 47.42B | 46.15B | 44.99B | 46.59B | 46.70B |
| Gross Profit | 4.68B | 4.93B | 4.42B | 3.60B | 3.54B | 3.75B |
| EBITDA | 3.49B | 3.60B | 3.71B | 2.94B | 2.93B | 3.17B |
| Net Income | 1.24B | 1.18B | 1.12B | 416.00M | 316.00M | 465.00M |
Balance Sheet | ||||||
| Total Assets | 36.87B | 39.15B | 36.91B | 36.89B | 37.69B | 39.11B |
| Cash, Cash Equivalents and Short-Term Investments | 2.44B | 2.11B | 2.33B | 1.97B | 2.23B | 1.84B |
| Total Debt | 1.07B | 220.00M | 370.00M | 1.37B | 2.51B | 4.43B |
| Total Liabilities | 11.24B | 11.66B | 11.21B | 11.88B | 13.20B | 14.98B |
| Stockholders Equity | 25.35B | 27.20B | 25.42B | 24.73B | 24.17B | 23.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 494.00M | 1.34B | 985.00M | 2.43B | 217.00M |
| Operating Cash Flow | 0.00 | 3.08B | 3.25B | 2.59B | 3.46B | 2.18B |
| Investing Cash Flow | 0.00 | -2.61B | -1.73B | -1.27B | -918.00M | -1.98B |
| Financing Cash Flow | 0.00 | -809.00M | -1.30B | -1.46B | -2.19B | -1.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥19.70B | 11.05 | ― | 2.46% | 0.69% | 11.33% | |
72 Outperform | ¥8.03B | 2.98 | ― | 1.67% | 1.44% | 184.02% | |
67 Neutral | ¥27.21B | 23.00 | ― | 2.00% | 2.77% | 5.83% | |
65 Neutral | ¥23.80B | 11.42 | ― | 2.82% | 2.71% | -5.60% | |
64 Neutral | ¥5.69B | 37.38 | ― | 1.62% | 8.05% | 65.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥3.41B | 20.34 | ― | 0.72% | 3.33% | 70.02% |